Winthrop Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-285	Closed	-$300K	–	168
2024 Q3	$300K	Sell	285 -2	-0.7%	-$2.1K	0.04%	115
2024 Q2	$302K	Sell	287 -8	-3%	-$8.41K	0.04%	109
2024 Q1	$284K	Sell	295 -5	-2%	-$4.81K	0.04%	119
2023 Q4	$263K	Buy	+300	New	+$263K	0.04%	115